Study type: Human research · Status: Verified against declared source

Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review

2018

Study scale: Not reported

Abstract only: Open source record

Product or molecular entity relationships

Cerebrolysin: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Cerebrolysin is a neuroprotective drug used in the treatment of acute ischemic stroke.

Methods

We retrospectively reviewed medical charts from patients with SAH who underwent aneurysmal occlusion at our institution between January 2007 and December 2016.

Scale or participants

Not reported in the reviewed source.

Key findings

Cerebrolysin is a neuroprotective drug used in the treatment of acute ischemic stroke.

Limitations and uncertainty

Aneurysmal subarachnoid hemorrhage (SAH) is a devastating disease with high morbidity and mortality.

Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.